BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20536521)

  • 1. Fasting plasma glucose and Type 2 diabetes risk: a non-linear relationship.
    Schulze MB; Fritsche A; Boeing H; Joost HG
    Diabet Med; 2010 Apr; 27(4):473-6. PubMed ID: 20536521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
    J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men.
    Park YW; Chang Y; Sung KC; Ryu S; Sung E; Kim WS
    Diabetes Res Clin Pract; 2006 Sep; 73(3):329-35. PubMed ID: 16600415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioural risk factors.
    Lecomte P; Vol S; Cacès E; Lasfargues G; Combe H; Laurent S; Tichet J
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):311-20. PubMed ID: 12442069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
    Nichols GA; Hillier TA; Brown JB
    Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting plasma glucose levels within the normoglycemic range in childhood as a predictor of prediabetes and type 2 diabetes in adulthood: the Bogalusa Heart Study.
    Nguyen QM; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Arch Pediatr Adolesc Med; 2010 Feb; 164(2):124-8. PubMed ID: 20124140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community.
    Harati H; Hadaegh F; Momenan AA; Ghanei L; Bozorgmanesh MR; Ghanbarian A; Mirmiran P; Azizi F
    Am J Prev Med; 2010 Jun; 38(6):628-636.e1. PubMed ID: 20494239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of abnormal fasting plasma glucose among the university hospital employees in Thailand.
    Jiamjarasrangsi W; Lohsoonthorn V; Lertmaharit S; Sangwatanaroj S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):343-9. PubMed ID: 17953998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.
    Andreozzi F; Succurro E; Mancuso MR; Perticone M; Sciacqua A; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal fasting plasma glucose levels and type 2 diabetes in young men.
    Tirosh A; Shai I; Tekes-Manova D; Israeli E; Pereg D; Shochat T; Kochba I; Rudich A;
    N Engl J Med; 2005 Oct; 353(14):1454-62. PubMed ID: 16207847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol consumption and higher incidence of impaired fasting glucose or type 2 diabetes in obese Korean men.
    Roh WG; Shin HC; Choi JH; Lee YJ; Kim K
    Alcohol; 2009 Dec; 43(8):643-8. PubMed ID: 20004342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
    Vaidya D; Kelemen MD; Bittner V; Tardif JC; Thompson P; Ouyang P
    J Womens Health (Larchmt); 2007 Mar; 16(2):228-34. PubMed ID: 17388739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies.
    Oh JY; Lim S; Kim DJ; Kim NH; Kim DJ; Moon SD; Jang HC; Cho YM; Song KH; Ahn CW; Sung YA; Park JY; Shin C; Lee HK; Park KS;
    Diabetes Res Clin Pract; 2008 Jun; 80(3):463-8. PubMed ID: 18339440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
    Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.